TMS Treatment Device Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
April 23, 2024
The FDA has recently granted clearance of a transcranial magnetic s...
Read More
Positive Phase 3 Topline Results Evaluating Lumateperone as Adjunctive Therapy for MDD
April 22, 2024
Encouraging results from a Phase 3 clinical trial evaluating lumate...
Read More
Highlights from 2024 NEI Synapse: The Road Forward: Guidelines for the Detection and Management of Treatment-Resistant Depression
April 19, 2024
Major depressive disorder (MDD) can be difficult to treat and if pa...
Read More
Use of SSRIs With Oral Anticoagulants and Risk of Major Bleeding
April 12, 2024
A recent population-based, nested case-control study assessed wheth...
Read More
FDA Clears First Prescription Digital Therapeutic Authorized for Treatment of MDD
April 1, 2024
The FDA has cleared the first prescription digital therapeutic auth...
Read More
Pharmacological Treatments for Psychotic Depression
March 22, 2024
Current treatment guidelines for psychotic depression recommend a c...
Read More
CDC Issues New Guidance on Identifying, Responding to Suicide Clusters
March 19, 2024
Responding to suicide clusters requires a comprehensive and proacti...
Read More
High Sugar Intake Tied to Increased Risk for Depression
March 11, 2024
A new cross-sectional study examined the association between dietar...
Read More
GLP-1 and Risk of Suicidal Ideation
January 30, 2024
A study investigated concerns regarding reports of suicidal ideatio...
Read More
Optimizing Treatment For Older Adults With Depression
January 4, 2024
Depression in older adults presents distinct difficulties due to it...
Read More
Comparison of Ketamine as Augmentation Treatment for Depression
December 19, 2023
Intravenous racemic ketamine may be a better augmentative treatment...
Read More
STAR-D For Adolescents?
December 8, 2023
Major depressive disorder (MDD) among adolescents carries high morb...
Read More